BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3914748)

  • 1. Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion.
    O'Reilly RJ; Collins N; Dinsmore R; Kernan N; Siena S; Brochstein J; Kirkpatrick D; Flomenberg N; Shank B; Dupont B
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):99-107. PubMed ID: 3914748
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.
    O'Reilly RJ; Keever C; Kernan NA; Brochstein J; Collins N; Flomenberg N; Laver J; Emanuel D; Dupont B; Cunningham I
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):55-60. PubMed ID: 3321647
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion.
    Woolfrey AE; Neudorf S; Filipovich AH
    Thymus; 1985; 7(6):327-34. PubMed ID: 3909540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell depletion from human bone marrow using magnetic beads.
    Knobloch C; Spadinger U; Rueber E; Friedrich W
    Bone Marrow Transplant; 1990 Jul; 6(1):21-4. PubMed ID: 2390629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency.
    Nespoli L; Porta F; Locatelli F; Aversa F; Carotti A; Lanfranchi A; Gibardi A; Marchesi ME; Abate L; Martelli MF
    Haematologica; 1990; 75(6):546-50. PubMed ID: 2098297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency.
    O'Reilly RJ; Brochstein J; Collins N; Keever C; Kapoor N; Kirkpatrick D; Kernan N; Dupont B; Burns J; Reisner Y
    Vox Sang; 1986; 51 Suppl 2():81-6. PubMed ID: 3532540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatched bone marrow transplantation in children with hematologic malignancy using T lymphocyte depleted bone marrow.
    Trigg ME; Sondel PM; Billing R; Finlay JL; Peterson A; Hong R; Frierdich S; Shahidi N
    J Biol Response Mod; 1985 Dec; 4(6):602-12. PubMed ID: 3910764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation.
    Champlin RE; Mitsuyasu RT; Gale RP
    Prog Clin Biol Res; 1985; 193():315-25. PubMed ID: 3911215
    [No Abstract]   [Full Text] [Related]  

  • 11. T-cell depletion and allogeneic bone marrow transplantation.
    O'Reilly RJ
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):20-6. PubMed ID: 1615341
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissociation between onset of natural killer E-rosette forming cells and of T3-positive cells following HLA-mismatched T cell depleted bone marrow transplantation.
    De Villartay JP; Le Deist F; Griscelli C; Fischer A
    Clin Exp Immunol; 1987 Feb; 67(2):406-14. PubMed ID: 3301094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
    Ogawa H; Ikegame K; Kawakami M; Taniguchi Y; Oka Y; Kawase I
    Haematologica; 2004 Mar; 89(3):373-5. PubMed ID: 15020286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow.
    Friedrich W; Goldmann SF; Vetter U; Fliedner TM; Heymer B; Peter HH; Reisner Y; Kleihauer E
    Lancet; 1984 Apr; 1(8380):761-4. PubMed ID: 6143084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings.
    Buckner CD; Clift RA; Fefer A; Lerner KG; Neiman PE; Storb R; Thomas ED
    Transplant Proc; 1974 Dec; 6(4):365-6. PubMed ID: 4612892
    [No Abstract]   [Full Text] [Related]  

  • 18. Low incidence of GvHD and rejection after pharmacological ex vivo modulation of bone marrow in 2-3 antigens mismatched BMT.
    de Manzini A; Andolina M; Agosti E; Giorgi R; Locatelli F; Bonetti L; Miniero R; Busca A; Porta F; Lanfranchi A
    Bone Marrow Transplant; 1993; 11 Suppl 1():114-6. PubMed ID: 8448533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute graft-versus-host disease and slow marrow recovery after transplantation of OKT8-positive T cell-depleted marrow from an HLA mismatched related donor. Kanazawa Bone Marrow Transplantation Team.
    Shiobara S; Harada M; Ohtuka M; Mori T; Matsuda T; Nibu K
    Transplant Proc; 1990 Feb; 22(1):257-9. PubMed ID: 2106742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.